Clinical Trial Update: Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase II clinical trial updating the study of platinum/etoposide chemotherapy plus Ivonescimab for extensive-stage small cell lung cancer is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Etoposide (Etoposide)
• Ivonescimab (AK112/SMT112)
• Platinum-based chemotherapy (platinum-based chemotherapy)

Snippet

Sponsor: PrECOG, LLC. | Conditions: Extensive Stage Lung Small Cell Cancer | Phase 2 | Status: RECRUITING